4//SEC Filing
Scholefield James H 4
Accession 0001225208-19-014013
CIK 0000310158other
Filed
Oct 31, 8:00 PM ET
Accepted
Nov 1, 5:04 PM ET
Size
8.2 KB
Accession
0001225208-19-014013
Insider Transaction Report
Form 4
Scholefield James H
EVP,Chief Info&Digital Officer
Transactions
- Exercise/Conversion
Common Stock
2019-10-30+11,436→ 11,436 total - Tax Payment
Common Stock
2019-10-30$85.10/sh−4,294$365,419→ 7,142 total - Exercise/Conversion
Restricted Stock Unit
2019-10-30$85.10/sh−11,436$973,204→ 22,872 totalFrom: 2019-10-30Exp: 2021-10-30→ Common Stock (11,436 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- [F2]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021.
Documents
Issuer
Merck & Co., Inc.
CIK 0000310158
Entity typeother
Related Parties
1- filerCIK 0001720922
Filing Metadata
- Form type
- 4
- Filed
- Oct 31, 8:00 PM ET
- Accepted
- Nov 1, 5:04 PM ET
- Size
- 8.2 KB